发明名称 PREVENTING AND TREATING AGENT OF BONE DISORDER ACCOMPANIED BY BONE FRACTURE AND REDUCTION OF BONE MASS
摘要 <P>PROBLEM TO BE SOLVED: To provide a method for not only boosting the induction of differentiation from mesenchymal stem cells and mesenchymal cells other than osteoblast cells to the osteoblast cells, but also markedly promoting the differentiation and maturation of the osteoblast cells, and further a preventing and treating agent of the bone disorder accompanied by bone fracture and the reduction of bone mass, especially a medicine applicable to a stent device for transplantation and artificial bone prosthetic material necessary for the treatment of the broken bone and regeneration treatment in the bone disorder such as the reduction of bone mass, etc. <P>SOLUTION: This method for promoting the differentiation from the mesenchymal cells to the osteoblast cells by simultaneous use of platelet rich plasma and bone formation-inducing protein; similarly the method for promoting the differentiation and maturation of the precursor cells of the osteoblast cells and/or the osteoblast cells; the agent for preventing and treating the bone disorder accompanied by the bone fracture and the reduction of the bone mass, comprising the simultaneous use of the platelet rich plasma and bone formation-inducing protein; and the osteoblast cells used for the prevention and treatment of the bone disorder accompanied by the bone fracture and reduction of the bone mass, prepared by culturing the mesenchymal cells in the presence of the platelet rich plasma and the bone formation-inducing protein are provided. <P>COPYRIGHT: (C)2009,JPO&INPIT
申请公布号 JP2008297220(A) 申请公布日期 2008.12.11
申请号 JP20070142412 申请日期 2007.05.29
申请人 METABOLOME PHARMACEUTICALS INC;SAITAMA MEDICAL UNIV 发明人 TOO KANJI;TANAI TAKEO;KATAGIRI TAKENOBU
分类号 A61K38/22;A61K35/12;A61K35/16;A61L27/00;A61P19/08;C12N5/077 主分类号 A61K38/22
代理机构 代理人
主权项
地址